迈得医疗：董事长、实控人林军华提议以2000万元-4000万元回购股份

Group 1 - The core point of the article is that Maide Medical announced a proposal by its chairman and actual controller, Lin Junhua, to repurchase a portion of the company's shares using either the proceeds from its initial public offering or its own funds to reduce the registered capital of the company [1] - The total amount of funds for the share repurchase will be no less than 20 million yuan (including) and no more than 40 million yuan (including) [1] - The repurchase will be conducted through centralized bidding transactions, and the repurchase price will not exceed 150% of the average trading price of the company's shares over the 30 trading days prior to the board's resolution on the repurchase [1]